TABLE 4.
§HBV DNA Reduction between wild-type control and heterozygote cases.
| All subjects | GG | GA | p # | |
|---|---|---|---|---|
| Baseline HBV DNA (68 pairs) | 5.94 ± 1.69 | 5.79 ± 1.76 | 6.09 ± 1.62 | 0.220 |
| ETV (55 pairs) | 5.88 ± 1.64 | 5.77 ± 1.63 | 5.98 ± 1.64 | 0.425 |
| TDF (13 pairs) | 6.16 ± 1.92 | 5.84 ± 2.32 | 6.52 ± 1.48 | 0.306 |
| 12 weeks HBV DNA reduction (68 pairs) | 4.63 ± 1.78 | 4.11 ± 1.64 | 5.15 ± 1.78 | <0.001 |
| ETV (55 pairs) | 4.62 ± 1.8 | 4.05 ± 1.64 | 5.18 ± 1.79 | <0.001 |
| TDF (13 pairs) | 4.66 ± 1.76 | 4.34 ± 1.71 | 5.02 ± 1.8 | 0.374 |
| 24 weeks HBV DNA reduction (68 pairs) | 5.13 ± 1.81 | 4.72 ± 1.76 | 5.54 ± 1.76 | 0.006 |
| ETV (55 pairs) | 5.19 ± 1.7 | 4.86 ± 1.62 | 5.52 ± 1.74 | 0.036 |
| TDF (13 pairs) | 4.87 ± 2.2 | 4.13 ± 2.26 | 5.62 ± 1.94 | 0.079 |
| 48 weeks HBV DNA reduction (50 pairs) | 5.48 ± 1.73 | 5.25 ± 1.9 | 5.6 ± 1.63 | 0.314 |
| ETV (38 pairs) | 5.4 ± 1.69 | 5.23 ± 1.79 | 5.4 ± 1.66 | 0.663 |
| TDF (12 pairs) | 5.74 ± 1.9 | 5.32 ± 2.3 | 6.22 ± 1.42 | 0.245 |
| 96 weeks HBV DNA reduction (43 pairs) | 5.6 ± 1.87 | 5.49 ± 1.82 | 5.65 ± 1.54 | 0.626 |
| ETV (38 pairs) | 5.6 ± 1.72 | 5.47 ± 1.75 | 5.68 ± 1.53 | 0.561 |
| TDF (5 pairs) | 5.57 ± 2.54 | 5.68 ± 2.55 | 5.47 ± 1.74 | 0.80 |
#p - value between GG and GA group. Significant p-value in bold (threshold p < 0.05).
§HBV DNA reduction defined as the HBV DNA load at each time point compared to baseline